XML 15 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Interim Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data
3 Months Ended9 Months Ended183 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Revenue     
Operating expenses:     
Research and development43911098841966,586
Impairment of capital assets    386
Gain on deferred lease inducements    (497)
Acquired in-process research and development    13,094
General and administrative5058071,5483,36930,153
Total operating expenses9449172,5363,788109,722
Loss from operations(944)(917)(2,536)(3,788)(109,722)
Other income (expense):     
Settlement of Cadherin litigation    (1,283)
Interest expense    (19)
Unrealized/realized(loss) gain on derivatives(2,221)2,5703,6832,498(432)
Other income 28 29254
Interest income and other211329212,800
Total other income (expense), net(2,200)2,6113,7122,5481,320
Net (loss)/income and total comprehensive (loss)/income$ (3,144)$ 1,694$ 1,176$ (1,240)$ (107,479)
Basic and diluted net (loss)/income per common share$ (0.17)$ 0.08$ 0.05$ (0.17) 
Weighted-average number of common shares outstanding, basic18,08520,46123,5927,124 
Weighted-average common shares outstanding, diluted18,08520,46123,7937,124